Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000895421-25-000188·C4 Therapeutics, Inc.
Schedule 13G ownership disclosure
C4 Therapeutics Inc
Common Stock · CUSIP: 12529R107
Event date: 2024-12-31
- Filing-level shares
- 3,828,810
- Percent of class
- 5.4%
- Morgan Stanley
Shares: 3,828,810 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000188
- Form type
- SCHEDULE 13G
- Filer
- C4 Therapeutics, Inc.
- CIK
- CIK 1662579
- Filed
- Feb 03, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership